Biotech · Public company · High Point, NC, US

vTv Therapeutics Inc.

Ticker VTVT · SEC CIK 0001641489

Track this companyFree. Adds vTv Therapeutics Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials62 recruiting or active

Pipeline programs7From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline7

AzeliragonPhase 3 · Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Azeliragon 5mgPhase 3 · Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Cadisegliatin 800 mg BIDPhase 3 · Diabetes Mellitus, Type 1ClinicalTrials.gov · fetched Nov 12, 2026
Cadisegliatin 800 mg QDPhase 3 · Diabetes Mellitus, Type 1ClinicalTrials.gov · fetched Nov 12, 2026
AzeliragonPhase 2 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Cadisegliatin 800 mg QDPhase 2 · Type 1 Diabetes (T1D)ClinicalTrials.gov · fetched Nov 12, 2026
TTP399Phase 2 · Diabetes Mellitus, Type 1ClinicalTrials.gov · fetched Nov 12, 2026

Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes Who Are Using Hybrid Closed Loop (HCL) SystemsPHASE2 · RECRUITING · started Sep 29, 2026ClinicalTrials.gov NCT07616206 · fetched Nov 12, 2026
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 DiabetesPHASE3 · ACTIVE_NOT_RECRUITING · started Jun 14, 2024ClinicalTrials.gov NCT06334133 · fetched Nov 12, 2026
Study of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose TolerancePHASE2 · TERMINATED · started Jun 27, 2019ClinicalTrials.gov NCT03980730 · fetched Nov 12, 2026
Evaluation of TTP399 in Patients With Type 1 DiabetesPHASE1_PHASE2 · COMPLETED · started Oct 25, 2017ClinicalTrials.gov NCT03335371 · fetched Nov 12, 2026
2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension)PHASE3 · TERMINATED · started Dec 1, 2016ClinicalTrials.gov NCT02916056 · fetched Nov 12, 2026
Evaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients With Mild Alzheimer's DiseasePHASE3 · TERMINATED · started Apr 1, 2015ClinicalTrials.gov NCT02080364 · fetched Nov 12, 2026